195 related articles for article (PubMed ID: 6408181)
41. Further studies on the C5-derived chemotactic factor for tumor cells.
Romualdez AG; Ward PA
Prog Clin Biol Res; 1976; 9():65-71. PubMed ID: 193134
[TBL] [Abstract][Full Text] [Related]
42. Digestion of the fifth component of complement by eosinophil lysosomal enzymes. Production of eosinophil specific chemotactic activity.
Ogawa H; Kunkel SL; Fantone JC; Ward PA
Virchows Arch B Cell Pathol Incl Mol Pathol; 1981; 38(2):149-57. PubMed ID: 6119842
[TBL] [Abstract][Full Text] [Related]
43. Changes in immunoreactivity for cathepsin H in rat type II alveolar epithelial cells and its proteolytic activity in bronchoalveolar lavage fluid over 24 hours.
Ishii Y; Hashizume Y; Kominami E; Uchiyama Y
Anat Rec; 1991 Aug; 230(4):519-23. PubMed ID: 1928757
[TBL] [Abstract][Full Text] [Related]
44. Generation of a complement-derived chemotactic factor for tumor cells in experimentally induced peritoneal exudates and its effect on the local metastasis of circulating tumor cells.
Orr FW; Mokashi S; Delikatny J
Am J Pathol; 1982 Jul; 108(1):112-8. PubMed ID: 7091299
[TBL] [Abstract][Full Text] [Related]
45. The role of C5 in polymorphonuclear leukocyte recruitment in response to Streptococcus pneumoniae.
Toews GB; Vial WC
Am Rev Respir Dis; 1984 Jan; 129(1):82-6. PubMed ID: 6703488
[TBL] [Abstract][Full Text] [Related]
46. Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity.
Venge P; Olsson I
J Immunol; 1975 Dec; 115(6):1505-8. PubMed ID: 1184964
[TBL] [Abstract][Full Text] [Related]
47. Complement component C5 is required for release of alveolar macrophage-derived neutrophil chemotactic activity.
Robbins RA; Russ WD; Thomas KR; Rasmussen JK; Kay HD
Am Rev Respir Dis; 1987 Mar; 135(3):659-64. PubMed ID: 3826892
[TBL] [Abstract][Full Text] [Related]
48. Detection of a complement-derived chemotactic factor for tumor cells in human inflammatory and neoplastic effusions.
Orr FW; Delikatny EJ; Mokashi S; Krepart GV; Stiver HG
Am J Pathol; 1983 Jan; 110(1):41-7. PubMed ID: 6185003
[TBL] [Abstract][Full Text] [Related]
49. Neutropenia induced by systemic infusion of chemotactic factors.
O'Flaherty JT; Showell HJ; Ward PA
J Immunol; 1977 May; 118(5):1586-9. PubMed ID: 858915
[TBL] [Abstract][Full Text] [Related]
50. Complement activation by myeloperoxidase products released from stimulated human polymorphonuclear leukocytes.
Vogt W
Immunobiology; 1996 Aug; 195(3):334-46. PubMed ID: 8877407
[TBL] [Abstract][Full Text] [Related]
51. Complement (C5)-derived chemotactic activity accounts for accumulation of polymorphonuclear leukocytes in cerebrospinal fluid of rabbits with pneumococcal meningitis.
Ernst JD; Hartiala KT; Goldstein IM; Sande MA
Infect Immun; 1984 Oct; 46(1):81-6. PubMed ID: 6480117
[TBL] [Abstract][Full Text] [Related]
52. Generation of C5a by phagocytic cells.
Huber-Lang M; Younkin EM; Sarma JV; Riedemann N; McGuire SR; Lu KT; Kunkel R; Younger JG; Zetoune FS; Ward PA
Am J Pathol; 2002 Nov; 161(5):1849-59. PubMed ID: 12414531
[TBL] [Abstract][Full Text] [Related]
53. Generation of biologic activity from the purified alpha-chain of C5.
Phan SH; Ward PA
J Immunol; 1979 Dec; 123(6):2735-40. PubMed ID: 501087
[TBL] [Abstract][Full Text] [Related]
54. Activation of neutrophils by factors released from alveolar macrophages stimulated with collagen-like polypeptides.
Laskin DL; Soltys RA; Berg RA; Riley DJ
Am J Respir Cell Mol Biol; 1990 May; 2(5):463-70. PubMed ID: 2160256
[TBL] [Abstract][Full Text] [Related]
55. Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis.
Goldblum SE; Van Epps DE; Reed WP
J Clin Invest; 1979 Jul; 64(1):255-64. PubMed ID: 447856
[TBL] [Abstract][Full Text] [Related]
56. Role of leukocytes in ocular inflammation of tyrosinemia II.
Ripple RE; Lohr KM; Twining SS; Hyndiuk RA; Caya JG
Invest Ophthalmol Vis Sci; 1986 Jun; 27(6):926-31. PubMed ID: 3519521
[TBL] [Abstract][Full Text] [Related]
57. PMN chemotactic factor produced by glass-adherent cells in the acute inflammation caused by Paracoccidioides brasiliensis.
Calich VL; Coppi Vaz CA; Burger E
Br J Exp Pathol; 1985 Feb; 66(1):57-65. PubMed ID: 3882118
[TBL] [Abstract][Full Text] [Related]
58. Variability of biological effects of silicas: different degrees of activation of the fifth component of complement by amorphous silicas.
Governa M; Amati M; Fenoglio I; Valentino M; Coloccini S; Bolognini L; Carlo Botta G; Emanuelli M; Pierella F; Volpe AR; Astolfi P; Carmignani M; Fubini B
Toxicol Appl Pharmacol; 2005 Oct; 208(1):68-77. PubMed ID: 16164962
[TBL] [Abstract][Full Text] [Related]
59. Neutrophil aggregation and swelling induced by chemotactic agents.
O'Flaherty JT; Kreutzer DL; Ward PA
J Immunol; 1977 Jul; 119(1):232-9. PubMed ID: 874320
[TBL] [Abstract][Full Text] [Related]
60. Characteristics of the chemotactic response of neoplastic cells to a factor derived from the fifth component of complement.
Orr W; Varani J; Ward PA
Am J Pathol; 1978 Nov; 93(2):405-22. PubMed ID: 568888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
